FINAL RESULTS FROM A PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA

被引：0
|
作者：
Lee, Eudocia [1 ,2 ]
Muzikansky, Alona [2 ,3 ]
Gerstner, Elizabeth [2 ,4 ]
Kuhn, John [5 ]
Reardon, David [1 ,2 ]
Nayak, Lakshmi [1 ,2 ]
Norden, Andrew [1 ]
Doherty, Lisa [1 ]
Stefanik, Jennifer [1 ]
Armitage, Julee [6 ]
LaFrankie, Debra [1 ]
Ruland, Sandra [1 ]
Vardam, Trupti [4 ]
Stokes, Deirdre [1 ]
Smith, Katrina [1 ]
McCluskey, Christine [1 ]
Gaffey, Sarah [1 ]
Batchelor, Tracy [2 ,4 ]
Jain, Rakesh [2 ,7 ]
Duda, Dan [2 ,7 ]
Wen, Patrick [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs, Boston, MA 02114 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-76
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma
    Smith, Katrina H.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Robins, Elizabeth
    Duda, Gerstner Dan G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Ruland, Sandra
    Pulverenti, Julee
    Stokes, Deirdre
    Lam, Priscilla
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Jain, Ftakesh K.
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Gerstner, Elizabeth Robins
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Pulverenti, Julee
    Vardam-Kaur, Trupti
    Stokes, Deirdre
    Smith, Katrina Howard
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Duda, Dan G.
    Jain, Rakesh K.
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma
    Lee, Eudocia Q.
    Duda, Dan G.
    Muzikansky, Alona
    Gerstner, Elizabeth R.
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew D.
    Doherty, Lisa
    LaFrankie, Debra
    Stefanik, Jennifer
    Vardam, Trupti
    Smith, Katrina H.
    McCluskey, Christine
    Gaffey, Sarah
    Batchelor, Tracy T.
    Jain, Rakesh K.
    Wen, Patrick Y.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4643 - 4649
  • [4] PHASE I STUDYOF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA
    Lee, Eudocia
    Smith, Katrina
    Muzikansky, Alona
    Gerstner, Elizabeth
    Kuhn, John
    Reardon, David
    Nayak, Lakshmi
    Norden, Andrew
    Rifenburg, Jennifer
    Pulverenti, Julee
    Stokes, Deirdre
    Lam, Priscilla
    Martins, Tiago
    Hempfling, Kelly
    McCluskey, Christine
    Gaffey, Sarah
    Batchelor, Tracy
    Duda, Dan
    Jain, Rakesh
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [5] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    J. Drappatz
    E. Q. Lee
    S. Hammond
    S. A. Grimm
    A. D. Norden
    R. Beroukhim
    M. Gerard
    D. Schiff
    A. S. Chi
    T. T. Batchelor
    L. M. Doherty
    A. S. Ciampa
    D. C. LaFrankie
    S. Ruland
    S. M. Snodgrass
    J. J. Raizer
    P. Y. Wen
    [J]. Journal of Neuro-Oncology, 2012, 107 : 133 - 138
  • [6] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    Drappatz, J.
    Lee, E. Q.
    Hammond, S.
    Grimm, S. A.
    Norden, A. D.
    Beroukhim, R.
    Gerard, M.
    Schiff, D.
    Chi, A. S.
    Batchelor, T. T.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Snodgrass, S. M.
    Raizer, J. J.
    Wen, P. Y.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) : 133 - 138
  • [7] BEVACIZUMAB AND CARBOPLATIN FOR RECURRENT HIGH-GRADE GLIOMA
    Mrugala, Maciej M.
    Lee, Laurie K.
    Graham, Carrie A.
    Fink, James R.
    Spence, Alexander M.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 55 - 55
  • [8] Phase I study of terameprocol in patients with recurrent high-grade glioma
    Grossman, Stuart A.
    Ye, Xiaobu
    Peereboom, David
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Supko, Jeffrey G.
    Desideri, Serena
    [J]. NEURO-ONCOLOGY, 2012, 14 (04) : 511 - 517
  • [9] A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).
    Drappatz, J.
    Raizer, J. J.
    Schiff, D.
    Chi, A. S.
    Batchelor, T.
    Snodgrass, S. M.
    Quant, E. C.
    Norden, A. D.
    Beroukhim, R.
    Grimm, S. A.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Gerard, M.
    Hammond, S.
    Wen, P. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 906 - 906
12345